Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCCa: Cediranib in Cervical Cancer
NCT01229930Phase 2Completed
- Sponsor
- University of Glasgow
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cervical Cancer (CC) comparing Placebo Arm with Cediranib Arm (2 arms). Primary endpoint: Overall Progression-Free Survival. Started Jun 2010; status: completed.
02
Drugs
cediranib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01229930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229930.